VedaBio
PrivateLast Round
Series A
Sep 23, 2025
Total Funding Raised
$80M
Company Overview
VedaBio is a biotechnology company that specializes in molecular diagnostics equipment, offering near-instant detection of multiple analytes with high accuracy and without the need for target amplification, thereby simplifying complex testing processes for medical researchers.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VedaBio Comps
Public and private peers based on sector, stage, and business model.
VedaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 23, 2025 | ||||
| Series A | Oct 17, 2023 |
Key People
Founding team and executive leadership
VedaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kleinmuntz Associates | Series A |
| OMX Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2025
$40M round completed.
- Sep 23, 2025
Signed a strategic agreement with Siemens Healthineers.
VedaBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VedaBio's valuation, stock price, and market status.
